Skip to main content

Table 5 Results of interaction analysis

From: A single-center retrospective study of factors related to the effects of intravenous glucocorticoid therapy in moderate-to-severe and active thyroid-associated ophthalmopathy

Factor

p-value

OR

95.0% CI of OR

Lower

Upper

Pretreatment CAS by duration of eye symptoms

0.002

0.983

0.972

0.994

Pretreatment CAS by restoration of euthyroidism

0.020

1.453

1.059

1.992

Duration of eye symptoms by restoration of euthyroidism

0.215

0.987

0.966

1.008

  1. OR Odds ratio, CI confidence interval, CAS clinical activity score
Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us